• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Onconova Therapeutics, Inc. (ONTX)

    -NasdaqGS
    2.70 Up 0.10(3.85%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 800   4,753   46,190  
    Cost of Revenue -   -   -  
    Gross Profit 800   4,753   46,190  
    Operating Expenses
    Research Development49,425  50,182  52,762  
    Selling General and Administrative15,119  16,793  15,707  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (63,744) (62,222) (22,279)
    Income from Continuing Operations
    Total Other Income/Expenses Net(30)105  975  
    Earnings Before Interest And Taxes(63,774)(62,117)(21,304)
    Interest Expense2  4  8,608  
    Income Before Tax(63,776)(62,121)(29,912)
    Income Tax Expense19  435   -  
    Minority Interest113  13   -  
    Net Income From Continuing Ops(63,682)(62,543)(29,912)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (63,682) (62,543) (29,912)
    Preferred Stock And Other Adjustments -  (2,320)(3,953)
    Net Income Applicable To Common Shares (63,682) (64,863) (33,865)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.